Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 2015
[PRIMARY MEDIASTINAL GERM CELL TUMOR ARISING IN A PATIENT WITH NEUROFIBROMATOSIS TYPE 1]Soki Kashima, Mitsuru Saito, Norihiko Tsuchiya, et al.
Medcomm|January 3, 2022
Altering phosphoinositides in high-fat diet-associated prostate tumor xenograft growthMingguo Huang, Atsushi Koizumi, Shintaro Narita, et al.
Disease Markers|May 7, 2015
Characterization of clinical and genetic risk factors associated with dyslipidemia after kidney transplantationKazuyuki Numakura, Hideaki Kagaya, Ryohei Yamamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 24, 2021
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective studyTakuma Narita, Shingo Hatakeyama, Kazuyuki Numakura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 26, 2016
[Outcome of Resection of Inferior Vena Cava Superior to the Renal Vein in Renal Cell Carcinoma with Vena Caval Tumor Thrombus]Soki Kashima, Shintaro Narita, Mitsuru Saito, et al.
In Vivo (Athens, Greece)|November 4, 2020
Does the Addition of Abiraterone to Castration Affect the Reduction in Bone Mineral Density?Shiori Nakajima, Takamitsu Inoue, Mingguo Huang, et al.
International Journal of Molecular Sciences|November 13, 2025
Inhibition of Fatty Acid-Binding Protein 4 Limits High-Fat-Diet-Associated Prostate Tumorigenesis and Progression in TRAMP MiceMingguo Huang, Shintaro Narita, Hiromi Sato, et al.
Cell Communication and Signaling : CCS|October 2, 2025
IGFBP2 alteration contributes to prostate cancer progression by modulating prostate stroma activationMingguo Huang, Shintaro Narita, Hiromi Sato, et al.
Pageof 19